FDA gives the OK to Siemens' linear accelerator
Siemens Medical Solutions USA Inc. has received FDA 510(k) clearance for its Oncor Avant-Garde linear accelerator.
Oncor integrates with technologies, such as the Optifocus MLC, a full-field, high-resolution multileaf collimator, and the Optivue amorphous silicon, flat-panel imaging system. The system also incorporates Siemens' Optibeam IMRT, an optimized technique for intensity modulated radiation therapy delivery that uses verification to safely provide treatments with speed and accuracy.
Oncor integrates with technologies, such as the Optifocus MLC, a full-field, high-resolution multileaf collimator, and the Optivue amorphous silicon, flat-panel imaging system. The system also incorporates Siemens' Optibeam IMRT, an optimized technique for intensity modulated radiation therapy delivery that uses verification to safely provide treatments with speed and accuracy.